Riskpilot← Back to searchSign inGet full accessGISLE RØD AS
ASActiveOrg 991253033Blomstervegen 14, 2005 RælingenGeneral medical practice activities · NACE 8621Est. 20072 employees
Revenue 2024
NOK 8,4M
+45% vs 2023
EBITDA margin
41.6%
+215% vs 2023
Equity ratio
77.9%
Financial strength
Net profit 2024
NOK 2,4M
+477% vs 2023
| Revenue | NOK 8,4M | +45% |
| EBITDA | NOK 3,5M | +215% |
| Net profit | NOK 2,4M | +477% |
| Total assets | NOK 12,3M | -2% |
| Equity | NOK 9,6M | +24% |
| Employees | 2 | — |
Legal name
GISLE RØD AS
Org number
991253033
Legal form
Aksjeselskap
NACE code
8621 · General medical practice activities
Founded
31. mai 2007
Share capital
NOK 100 000
Employees
2 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Legevirksomhet, handel, utleie av faste eiendommer, konsulentvirksomhet, deltakelse i andre selskaper og hva dermed står i forbindelse.
Address
Blomstervegen 14, 2005 Rælingen
Phone
+4767906676
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 5 427 | 5 634 | 6 213 | 5 787 | 8 399 |
| Staff expenses | −1 249 | −1 425 | −1 750 | −1 693 | −1 597 |
| EBITDA | 1 657 | 1 399 | 1 380 | 1 111 | 3 497 |
| Depreciation & amort. | −82 | −82 | −294 | −326 | −316 |
| EBIT | 1 575 | 1 317 | 1 086 | 785 | 3 181 |
| Net financials | −85 | −94 | −185 | −244 | −85 |
| Profit before tax | 1 490 | 1 223 | 900 | 541 | 3 096 |
| Tax | 328 | 269 | 198 | 119 | 659 |
| Net profit | 1 162 | 954 | 703 | 422 | 2 437 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 9 741 | 12 578 | 12 789 | 12 568 | 12 330 |
| Equity | 6 595 | 6 949 | 7 352 | 7 774 | 9 611 |
| Long-term debt | 1 920 | 3 762 | 3 793 | 3 378 | 1 110 |
| Short-term debt | 1 225 | 1 866 | 1 644 | 1 416 | 1 609 |
| Total debt | 3 145 | 5 629 | 5 437 | 4 794 | 2 719 |
EBITDA margin
41.6%
This company
15.8%
Market median
+163% vs market
20202024
Equity ratio
77.9%
This company
38.2%
Market median
+104% vs market
20202024
Return on equity
25.4%
This company
18.4%
Market median
+38% vs market
20202024
Net profit margin
29.0%
This company
8.1%
Market median
+258% vs market
20202024
Asset turnover
0.68×
This company
1.12×
Market median
-39% vs market
20202024
Debt / equity
0.28×
This company
0.62×
Market median
+55% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
TR Deputy Member | Deputy Member | 2007 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2007 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.